Health Net 2013 Annual Report Download - page 63
Download and view the complete annual report
Please find page 63 of the 2013 Health Net annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53 -
54 -
55 -
56 -
57 -
58 -
59 -
60 -
61 -
62 -
63 -
64 -
65 -
66 -
67 -
68 -
69 -
70 -
71 -
72 -
73 -
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
 |
 |
61
material impact on our operating results or financial condition. In addition, our operating results for the year ended December 31, 2013
were impacted by $12.0 million in pretax costs primarily related to our continuing efforts to address scale issues. For 2012, includes a gain
on sale of discontinued operation in the amount of $114.8 million after-tax. Our operating results for the year ended December 31, 2012
were impacted by approximately $35 million of adverse development related to prior years recorded as part of our health care cost. In
addition, our operating results for the year ended December 31, 2012 were impacted by pretax costs of $35.6 million related to our G&A
cost reduction efforts, a $5.0 million expense related to the early termination of a medical management contract and $1.3 million in
litigation-related expenses net of an insurance reimbursement. For 2011, includes a $181 million pretax expense related to a litigation
judgment in the first quarter. In addition, our operating results for the year ended December 31, 2011 were impacted by a $40.8 million
favorable adjustment to loss on sale of Northeast health plan subsidiaries and a $6.8 million benefit from litigation reserve adjustments,
partially offset by pretax costs of $25.2 million related to our G&A cost reduction efforts. For 2010, includes pretax charges of $61.2
million related to our operations strategy and other cost management initiatives, and $9.0 million in early debt extinguishment and related
interest rate swap termination costs, partially reduced by a $46.5 million benefit from litigation reserve adjustments and a $42.0 million
adjustment to loss on sale of Northeast health plan subsidiaries. For 2009, includes pretax charges of $105.9 million for loss on Northeast
Sale, $174.9 million of asset impairment on Northeast operations and $123.6 million related to our operations strategy, reductions for
litigation reserve adjustments and Northeast Sale-related expenses.
(2) No cash dividends were declared in any of the years presented.